T1	Outcomes 100 120	antiretroviral-naive
T2	Outcomes 460 468	efficacy
T3	Outcomes 473 479	safety
T4	Outcomes 740 778	baseline median plasma HIV-1 RNA level
T5	Outcomes 1053 1075	plasma HIV-1 RNA level
T6	Outcomes 1203 1235	infrequency of virologic failure
T7	Outcomes 1250 1317	emergence of resistance mutations, CD4 cell increases from baseline
T8	Outcomes 1350 1421	safety profile, and incidence of ABC-related hypersensitivity reactions
